“Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1), p. e2026001. doi:10.4084/MJHID.2026.001.